← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Bendamustinhydrochlorid-Monohydrat currently has availability issues reported in 3 European registers: Germany, Spain, Sweden.
Shortage ATC L01AA09 · also listed as: Bendamustinhydrochlorid-Monohydrat · BENDAMUSTINA · bendamustinhydroklorid · data refreshed 13 September 2026
As of 13 September 2026, 3 of the 9 tracked registers list current availability issues for Bendamustinhydrochlorid-Monohydrat, covering 8 affected product presentations. The longest-running open report was filed in Germany on 2022-05-01 and has now been open for about 52 months. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-11-29. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. The issue spread across registers over time rather than at once: Germany reported first (2022-05-01), with Sweden following roughly 49 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Bendamustinhydrochlorid-Monohydrat is coded L01AA09 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Bendamustin beta 180 mg/4 ml Konzentrat zur Herstellung einer Infusionslösung | 2022-05-01 | 2026-12-31 | Sonstige Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage BENDAMUSTINA ACCORD 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 5 viales de 100 mg + 5 more productsBENDAMUSTINA ACCORD 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 5 viales de 4 ml BENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mg BENDAMUSTINA BAXTER 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG 5 viales de 100 mg BENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mg BENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 25 mg | 2025-05-11 | 2026-12-30 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇸🇪 Sweden | Shortage Bendamustine Accord 2,5 mg/ml Pulver till konc. till infusionsvätska, lösning | 2026-06-01 | 2026-07-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Bendamustinhydrochlorid-Monohydrat in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Bendamustine Accord 2,5 mg/ml Pulver till konc. till infusionsvätska, | Shortage | 2026-06-01 | 2026-07-31 | |
| 🇪🇸 ES | BENDAMUSTINA ACCORD 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | Shortage | 2026-05-19 | 2026-12-30 | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | BENDAMUSTINA ACCORD 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PAR | Shortage | 2026-02-26 | 2026-12-30 | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | BENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION | Shortage | 2025-10-21 | 2026-11-29 | |
| 🇪🇸 ES | BENDAMUSTINA BAXTER 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PAR | Shortage | 2025-06-18 | — | |
| 🇪🇸 ES | BENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION | Shortage | 2025-06-03 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | BENDAMUSTINA DR. REDDYS 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION | Shortage | 2025-05-11 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇩🇪 DE | Bendamustin beta 180 mg/4 ml Konzentrat zur Herstellung einer Infusion | Shortage | 2022-05-01 | 2026-12-31 | Sonstige |
Yes. As of 13 September 2026, availability issues are reported in: Germany, Spain, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-11-29 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
6 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Bendamustinhydrochlorid-Monohydrat: BfArM (Germany), AEMPS CIMA (Spain), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bendamustinhydrochlorid-Monohydrat — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bendamustinhydrochlorid-monohydrat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bendamustinhydrochlorid-Monohydrat availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bendamustinhydrochlorid-monohydrat/">Bendamustinhydrochlorid-Monohydrat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>